
Optimization of the phenylurea moiety in a phosphoinositide 3-kinase (PI3K) inhibitor to improve water solubility and the PK profile by introducing a solubilizing group and ortho substituents
Keywords: PI3K; Cancer; SBDD; Molecular planarity; Solubility; Pharmacokinetic profile